Immune reconstitution inflammatory syndrome in the lung in non-human immunodeficiency virus patients

Respir Investig. 2020 Jan;58(1):36-44. doi: 10.1016/j.resinv.2019.11.001. Epub 2019 Nov 29.

Abstract

Background: We evaluated immune reconstitution inflammatory syndrome (IRIS) in the lung in non-human immunodeficiency virus (HIV) patients.

Methods: We reviewed articles related to IRIS occurrence in the lung in non-HIV patients using a PubMed search. The keywords used for the search were "immune reconstitution syndrome" and "non-HIV." Only patients with lung involvement were included. Those with suggested IRIS caused by white blood cell recovery were excluded.

Results: There were 37 cases of IRIS in the lung in non-HIV patients. Complicating infections included tuberculosis (n = 17), histoplasmosis (n = 9), aspergillosis (n = 5), cryptococcosis (n = 4), and Pneumocystis pneumonia (n = 2). We also evaluated the underlying diseases, IRIS pathogenesis, management, and prognosis. IRIS was most commonly encountered in patients treated with anti-tumor necrosis factor (TNF) antibody who developed disseminated or extrapulmonary tuberculosis, leading to treatment discontinuation.

Conclusions: The diagnosis and management of IRIS in the lung in non-HIV patients should be investigated further, especially in the era of anti-TNF treatment.

Keywords: Anti-tumor necrosis factor; Immune reconstitution inflammatory syndrome; Lung; Non-HIV patients.

Publication types

  • Systematic Review

MeSH terms

  • Humans
  • Immune Reconstitution Inflammatory Syndrome* / diagnosis
  • Immune Reconstitution Inflammatory Syndrome* / therapy
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha